Non-Small Cell Lung Cancer (NSCLC) NewsLatest News On Non-Small Cell Lung Cancer (NSCLC) ASCO 2025: New Tools for Lung Cancer, Harder Job for Clinicians8/13/2025 12:55 PM FDA Approves Zongertinib for HER2-Mutated NSCLC8/8/2025 5:52 PM EMR Nudges to Increase Molecular Genotyping in Patients With NSCLC7/31/2025 9:10 AM Sunvozertinib Wins Approval for EGFR-Mutated NSCLC7/3/2025 12:43 PM Datroway Gains Second FDA Nod With NSCLC Approval6/23/2025 5:27 PM EGFR+ NSCLC: Experts Weigh Risk vs Reward at ASCO 20256/20/2025 9:32 AM Is It Worth Adding Chemo to ICI for NSCLC in Older Adults?6/19/2025 9:53 AM Nivolumab Plus Chemotherapy Before Surgery Improves Survival in Lung Cancer6/12/2025 11:48 PM Taletrectinib Approved for NSCLC6/11/2025 5:43 PM
